Skip to main content
Signal8

CapForce Inc. (CFOR)

CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.

Sector: Services-Management Consulting Services

Industry: Financial - Capital Markets

CapForce Inc. logo

CapForce Inc.

OTC:CFORFinancial Services
AH+0.00%$6.00
Close$6.00+6.19%
Mkt Cap$74.77M
EV-
Float2.42M
O/S12.46M
VOL3K sh
$ Vol$17K
RVOL1.27×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
CapForce Inc. logoOTC:CFORAH$6.00+0.00%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 2.42M · Signal8 dilution snapshot · Oct 30, 2026

87
Oct 30 (18d)prev 3▲ 2800.0%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow CFOR shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
28.4%
Nov 16 (1d)prev 0.6%▲ 27.8 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis16 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202687 sh
Oct 15, 20263 sh
Sep 30, 20263 sh
Sep 15, 20263 sh
Aug 31, 20263 sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202628.4%
Nov 12, 20260.6%
Nov 11, 202614.9%
Nov 10, 202617.2%
Nov 9, 202629.1%
33-session median 29.7%mean 35.0%range 0.2–91.6%

130 calendar days requested; 34 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for CFOR: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 87 CFOR shares were sold short (<0.01% of a 2.42M-share float, 1.00 days to cover).